Randomized Clinical Trial
Copyright ©The Author(s) 2022.
World J Clin Cases. Mar 26, 2022; 10(9): 2792-2800
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2792
Table 1 Basic characteristics of the two groups of patients
Basic characteristics
Age (yr)
Gleason score
PSA (ng/mL)
Tumor type
Adenocarcinoma
Epithelial cancer
Squamous cell carcinoma
Other
Routine nursing group (n = 45)70.36 ± 7.215.69 ± 1.5513.34 ± 2.63261252
Peplau nursing group (n = 44)70.16 ± 5.665.86 ± 1.9614.36 ± 2.87291032
t/χ2 value0.1430.4671.7490.834
P value0.8870.6420.0840.841
Table 2 Comparison of incontinence by group
Group
n
Duration (d)
Frequency (times/d)
Amount (L)
Routine nursing group457.13 ± 2.428.22 ± 2.751.24 ± 0.42
Peplau nursing group444.75 ± 1.844.20 ± 1.210.56 ± 0.11
t value5.2208.82710.395
P value0.0130.0000.000
Table 3 Comparison of international prostate symptom score and Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Scale scores by group (mean ± SD, scores)
Group
n
IPSS score
t value
P
FACIT-Sp score
t value
P value
Before
After
Before
After
Routine nursing group4526.68 ± 3.5417.20 ± 2.6414.4210.0005.46 ± 1.467.47 ± 2.454.1580.000
Peplau nursing4425.87 ± 3.9611.75 ± 2.0521.8630.0005.68 ± 1.5410.48 ± 3.179.0510.000
t value1.03710.8600.6785.027
P value0.3020.0000.4990.000
Table 4 Comparison of quality of life scores by group (mean ± SD, scores)
Group
n
QOL score
t value
P value
Before
After
Peplau nursing4420.11 ± 3.2232.80 ± 3.8916.0890.000
Routine nursing group4520.07 ± 3.9445.53 ± 4.6128.1790.000
t value0.06114.070
P value0.9510.000